Personalized Instrument for Total Shoulder Arthroplasty
(PITSA Trial)
Trial Summary
What is the purpose of this trial?
Total shoulder arthroplasty is an effective procedure to improve patients function and to relieve shoulder pain in cases of glenohumeral arthritis. The main challenge of this procedure is implanting the glenoid component. Indeed, surgical exposure is difficult and proper visualization of the glenoid is demanding. The current free-hand method is not precise and especially unreliable in glenoids with severe deformity. Inappropriate reaming and glenoid positioning can cause more bone loss during surgery. In anatomic prostheses, glenoid component fixation is demanding and is the first component to present loosening at long term follow-up. When it comes to reverse arthroplasty, the glenoid component, once again, requires the most attention. Malpositioning of the glenosphere can cause notching, loosening, and instability. In order to prevent these complications, precision in glenoid implantation is key. To this end, intraoperative computer navigation would be a helpful tool, but the increased expenses in computer equipment represent massive costs and possibly increases in surgical time. A more affordable option is a personalized guide, for which the only extra expense is the customized guide. These guides are based on precise 3D CT scan templates. Previous studies have evaluated the precision of the guide in vivo and in vitro, but none have measured it in a randomized study. As it represents additional costs, its efficacy needs to be proven before widespread use. This method may also provide secondary benefits, such as decreasing operating time, lowering short- and long-term complications, and improving efficacy. The objective of this study is to evaluate the performance of a patient specific glenoid guide.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Personalized Instrument for Total Shoulder Arthroplasty?
Research shows that reverse total shoulder arthroplasty (RTSA) is effective as a revision procedure for failed anatomic total shoulder arthroplasty (TSA), especially in cases with massive irreparable rotator cuff tears. RTSA allows for reconstruction without removing well-fixed components, making it a less extensive procedure.12345
Is shoulder replacement surgery generally safe for humans?
What makes the Personalized Instrument for Total Shoulder Arthroplasty treatment unique compared to other shoulder replacement options?
This treatment is unique because it uses personalized instruments to perform shoulder arthroplasty, allowing for a more tailored approach to surgery. It also offers the flexibility to convert from an anatomic to a reverse total shoulder arthroplasty without removing well-fixed components, which can simplify revision surgeries.12345
Research Team
Dominique Rouleau, MD
Principal Investigator
Université de Montréal
Eligibility Criteria
This trial is for patients with shoulder osteoarthritis and AVN who haven't had previous shoulder replacements or surgeries involving metal implants. Participants must speak English or French, agree to a 2-year follow-up, and have no history of shoulder infections, inflammatory arthritis, or tumors.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Assessment
Preoperative status characterized by demographic data, range of motion, quality of life, and functional status. CT Scan and x-rays are collected.
Surgery
Participants undergo total shoulder arthroplasty using either the patient-specific glenoid guide or the classic method.
Immediate Postoperative Follow-up
Radiological evaluation to compare the precision of glenoid implantation.
Long-term Follow-up
Participants are monitored for glenoid fixation and bone loss.
Treatment Details
Interventions
- RTSA Blueprint
- RTSA standard
- TSA Blueprint
- TSA standard
RTSA Blueprint is already approved in European Union, United States, Canada for the following indications:
- Irreparable rotator cuff tears
- Aseptic necrosis of the humeral head
- Revision surgery following failed anatomical or resurfacing arthroplasty
- Rotator cuff-deficient shoulders
- Complex fractures
- Degenerative shoulder diseases
- Shoulder arthritis
- Posttraumatic osteoarthritis
- Inflammatory arthropathy
Find a Clinic Near You
Who Is Running the Clinical Trial?
Université de Montréal
Lead Sponsor